Advertisement
Screener

Intersect ENT, Inc. Accounts Receivable, before Allowance for Credit Loss, Current

Intersect ENT, Inc. Accounts Receivable, before Allowance for Credit Loss, Current

Intersect ENT, Inc. had Accounts Receivable, before Allowance for Credit Loss, Current of $13.76 million as of 2022-03-31, per its 10-Q filed 2022-05-04.

Discontinued › Balance Sheet › Assets › Assets, Current › Accounts Receivable, after Allowance for Credit Loss, Current

us-gaap:AccountsReceivableGrossCurrent · last filed 2022-05-04

  • 2022-03-31: Accounts Receivable, before Allowance for Credit Loss, Current $13.76M.
  • 2021-12-31: Accounts Receivable, before Allowance for Credit Loss, Current $17.95M.
  • 2021-09-30: Accounts Receivable, before Allowance for Credit Loss, Current $14.80M.
  • 2021-06-30: Accounts Receivable, before Allowance for Credit Loss, Current $16.39M.
Period endAccounts Receivable, before Allowance for Credit Loss, Current
2022-03-31$13.76M
10-Q · filed 2022-05-04
2021-12-31$17.95M
10-Q · filed 2022-05-04
2021-09-30$14.80M
10-Q · filed 2021-11-02
2021-06-30$16.39M
10-Q · filed 2021-08-06
2021-03-31$14.93M
10-Q · filed 2021-05-10
2020-12-31$15.08M
10-K · filed 2022-03-08
2020-09-30$12.09M
10-Q · filed 2020-11-02
2020-06-30$7.92M
10-Q · filed 2020-08-05
2020-03-31$10.55M
10-Q · filed 2020-05-11
2019-12-31$19.24M
10-K · filed 2021-03-09
2019-09-30$13.33M
10-Q · filed 2019-11-05
2019-06-30$15.63M
10-Q · filed 2019-08-05
2019-03-31$17.40M
10-Q · filed 2019-05-07
2018-12-31$19.70M
10-K · filed 2020-02-27
2018-09-30$14.50M
10-Q · filed 2018-11-05
2018-06-30$14.75M
10-Q · filed 2018-08-03
2018-03-31$14.41M
10-Q · filed 2018-05-03
2017-12-31$16.74M
10-K · filed 2019-02-28
2017-09-30$11.78M
10-Q · filed 2017-11-06
2017-06-30$12.39M
10-Q · filed 2017-08-04
2017-03-31$12.52M
10-Q · filed 2017-05-05
2016-12-31$14.58M
10-K · filed 2018-02-28
2016-09-30$10.07M
10-Q · filed 2016-11-03
2016-06-30$10.10M
10-Q · filed 2016-08-08
2016-03-31$9.61M
10-Q · filed 2016-05-09
2015-12-31$11.55M
10-K · filed 2017-02-28
2014-12-31$8.34M
10-K · filed 2016-02-25